Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: breast cancer cell

Results 1 - 100 of 309 > >>
EC Number Recommended Name Source Tissue Commentary Reference
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) breast cancer cell - 700197
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) breast cancer cell expression of the enzyme and the estrogen receptor is correlated 668162
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell - 656788, 763397
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell 3beta-hydroxysteroid dehydrogenase type 1 693887
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell isozyme 3beta-HSD1 662371
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase breast cancer cell 18fold increase in the median AKR1C3 mRNA levels in breast cancer patients as compared to those without disease 697271
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase breast cancer cell of invasive ductal carcinoma of the breast, immunohistochemical analysis 740999
Show all pathways known for 1.1.1.205Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.205IMP dehydrogenase breast cancer cell - 761611
Show all pathways known for 1.1.1.213Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2133alpha-hydroxysteroid 3-dehydrogenase (Re-specific) breast cancer cell - 675678
Show all pathways known for 1.1.1.27Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.27L-lactate dehydrogenase breast cancer cell - 740255
Show all pathways known for 1.1.1.27Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.27L-lactate dehydrogenase breast cancer cell normal and malignant human breast tissues. The enzyme is highly expressed in breast 740253
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell 17beta-HSD7 is amplified in primary and progressive breast cancer 763396
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell 3beta-HSD1 is selectively expressed in human placenta, mammary glands and breast tumors in women 763397
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell expression of 3beta-hydroxysteroid dehydrogenase type 1 (HSD3B1) in breast cancer is associated with shorter recurrence-free survival, and genetic or pharmacologic inhibition of HSD3B1 reduced colony formation and xenograft growth 763404
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell selective expression of 3beta-HSD1 725813
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.3573alpha-hydroxysteroid 3-dehydrogenase breast cancer cell - 740017
Show all pathways known for 1.1.1.37Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.37malate dehydrogenase breast cancer cell - 760668
Show all pathways known for 1.1.1.40Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.40malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) breast cancer cell - 761332
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.503alpha-hydroxysteroid 3-dehydrogenase (Si-specific) breast cancer cell - 740017
Show all pathways known for 1.1.1.51Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.513(or 17)beta-hydroxysteroid dehydrogenase breast cancer cell - 761900
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell - 685545, 711649, 713021, 726302, 740542, 740839, 740849, 761756, 761900
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell 17beta-HSD1 is overexpressed in many breast tumors 688272
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell the inhibition of the enzyme (17beta-HSD7) constitutes the basis of breast cancer cell proliferation 761756
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.8glycerol-3-phosphate dehydrogenase (NAD+) breast cancer cell - 287331
Display the word mapDisplay the reaction diagram Show all sequences 1.11.1.12phospholipid-hydroperoxide glutathione peroxidase breast cancer cell - 659398
Show all pathways known for 1.13.11.33Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.33arachidonate 15-lipoxygenase breast cancer cell - 676925
Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.53acireductone dioxygenase (Ni2+-requiring) breast cancer cell - 764226
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.16peptide-aspartate beta-dioxygenase breast cancer cell - 742572
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.16peptide-aspartate beta-dioxygenase breast cancer cell highly expressed 439254
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.2procollagen-proline 4-dioxygenase breast cancer cell P4HA2 mRNA levels are significantly upregulated in breast cancer compared to normal mammary tissue 744594
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.27[histone H3]-dimethyl-L-lysine36 demethylase breast cancer cell - 745919
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.4procollagen-lysine 5-dioxygenase breast cancer cell - 725955
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.53mRNA N6-methyladenine demethylase breast cancer cell - 739559, 765377
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.65[histone H3]-dimethyl-L-lysine9 demethylase breast cancer cell - 701223
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.66[histone H3]-trimethyl-L-lysine9 demethylase breast cancer cell - 711677, 756531
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.67[histone H3]-trimethyl-L-lysine4 demethylase breast cancer cell high expression level of JARID1B 711581
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.7procollagen-proline 3-dioxygenase breast cancer cell - 697017
Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.8flavin-containing monooxygenase breast cancer cell - 673313
Show all pathways known for 1.14.14.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.18heme oxygenase (biliverdin-producing) breast cancer cell - 728211
Show all pathways known for 1.14.15.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.18calcidiol 1-monooxygenase breast cancer cell - 671357, 695621
Show all pathways known for 1.14.15.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.18calcidiol 1-monooxygenase breast cancer cell the enzyme expression is reduced in breast cancer cell specimen compared to healthy breast tissue 672857
Show all pathways known for 1.14.19.17Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.17sphingolipid 4-desaturase breast cancer cell - 744398, 744686
Show all pathways known for 1.15.1.1Display the word mapDisplay the reaction diagram Show all sequences 1.15.1.1superoxide dismutase breast cancer cell harbors MnSOD with the ala16val polymorphism 716197
Show all pathways known for 1.2.1.12Display the word mapDisplay the reaction diagram Show all sequences 1.2.1.12glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) breast cancer cell - 743173
Show all pathways known for 1.2.1.3Display the word mapDisplay the reaction diagram Show all sequences 1.2.1.3aldehyde dehydrogenase (NAD+) breast cancer cell - 697114
Show all pathways known for 1.2.1.31Display the word mapDisplay the reaction diagram Show all sequences 1.2.1.31L-aminoadipate-semialdehyde dehydrogenase breast cancer cell - 675897
Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.1dihydropyrimidine dehydrogenase (NAD+) breast cancer cell - 686604, 688302, 689367
Display the word mapDisplay the reaction diagram Show all sequences 1.4.3.13protein-lysine 6-oxidase breast cancer cell - 687920, 713156
Display the word mapDisplay the reaction diagram Show all sequences 1.4.3.13protein-lysine 6-oxidase breast cancer cell circulating 700903
Display the word mapDisplay the reaction diagram Show all sequences 1.4.3.13protein-lysine 6-oxidase breast cancer cell hypoxic 697071
Display the word mapDisplay the reaction diagram Show all sequences 1.4.3.13protein-lysine 6-oxidase breast cancer cell lymph node-negative breast adenocarcinoma cell 685957
Show all pathways known for 1.5.1.2Display the word mapDisplay the reaction diagram Show all sequences 1.5.1.2pyrroline-5-carboxylate reductase breast cancer cell - 762877
Show all pathways known for 1.5.3.13Display the word mapDisplay the reaction diagram Show all sequences 1.5.3.13N1-acetylpolyamine oxidase breast cancer cell - 703028
Show all pathways known for 1.5.3.16Display the word mapDisplay the reaction diagram Show all sequences 1.5.3.16spermine oxidase breast cancer cell - 690800, 711592
Display the word mapDisplay the reaction diagram Show all sequences 1.6.3.1NAD(P)H oxidase (H2O2-forming) breast cancer cell - 742556
Show all pathways known for 1.8.1.9Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.9thioredoxin-disulfide reductase breast cancer cell - 675915
Display the word mapDisplay the reaction diagram Show all sequences 1.8.3.2thiol oxidase breast cancer cell expression analysis of a panel of cDNAs derived from 50 clinically-graded normal and malignant breast tissue samples for the expression of QSOX1 mRNAs, significant correlation between relative transcript level and clinical grade malignant breast tumors 743627
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.100protein-S-isoprenylcysteine O-methyltransferase breast cancer cell - 704546
Show all pathways known for 2.1.1.17Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.17phosphatidylethanolamine N-methyltransferase breast cancer cell - 697843
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.220tRNA (adenine58-N1)-methyltransferase breast cancer cell - 721024
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.244protein N-terminal methyltransferase breast cancer cell - 736919
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.348mRNA m6A methyltransferase breast cancer cell - 756331
Show all pathways known for 2.1.1.355Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.355[histone H3]-lysine9 N-trimethyltransferase breast cancer cell - 755156
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.357[histone H3]-lysine36 N-dimethyltransferase breast cancer cell - 753720
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.361[histone H4]-lysine20 N-methyltransferase breast cancer cell - 753133
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.56mRNA (guanine-N7)-methyltransferase breast cancer cell - 757896
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.6catechol O-methyltransferase breast cancer cell - 658443, 702678
Show all pathways known for 2.1.2.1Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.1glycine hydroxymethyltransferase breast cancer cell expression patterns of SHMT2 in 76 breast cancer patients after modified radical mastectomy, immunohistochemic analysis, SHMT2 is highly expressed in breast cancer cells, and the expression level of SHMT2 is positively correlated with breast cancer grade 736925
Show all pathways known for 2.1.2.2Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.2phosphoribosylglycinamide formyltransferase 1 breast cancer cell - 756648
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3phosphoribosylaminoimidazolecarboxamide formyltransferase breast cancer cell - 756648
Show all pathways known for 2.2.1.1Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.1transketolase breast cancer cell TKTL1 expression in 86% of breast cancer specimens with 45% showing high expression levels 694502
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.135phosphatidylcholine-retinol O-acyltransferase breast cancer cell neoplastic and adjacent, non-neoplastic glandular breast tissue specimens from human patients, expression analysis, reduced enzyme expression, LRAT protein progressively decreases with a reduction in the degree of tumor differentiation in invasive breast carcinomas, overview 674069
Show all pathways known for 2.3.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.21carnitine O-palmitoyltransferase breast cancer cell - 757235
Show all pathways known for 2.3.1.24Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.24sphingosine N-acyltransferase breast cancer cell isozymes CerS2 (EC 2.3.1.297) and CerS6 (EC 2.3.1.24) mRNA is significantly elevated in breast cancer tissue compared to normal tissue, with approximately half of the individuals showing elevated CerS2 and CerS6 mRNA. A significant correlation is found between CerS2 and CerS6 isozyme expression, and between isozymes CerS4 (EC 2.3.1.24) and CerS2/CerS6 expression 752644
Display the reaction diagram Show all sequences 2.3.1.291sphingoid base N-palmitoyltransferase breast cancer cell - 752733
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.297very-long-chain ceramide synthase breast cancer cell isozymes CerS2 (EC 2.3.1.297) and CerS6 (EC 2.3.1.24) mRNA is significantly elevated in breast cancer tissue compared to normal tissue, with approximately half of the individuals showing elevated CerS2 and CerS6 mRNA. A significant correlation is found between CerS2 and CerS6 isozyme expression, and between isozymes CerS4 (EC 2.3.1.24) and CerS2/CerS6 expression 752644
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.45N-acetylneuraminate 7-O(or 9-O)-acetyltransferase breast cancer cell - 677235
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.48histone acetyltransferase breast cancer cell - 703846, 735352, 756658, 756850, 758109
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell - 735771, 735849, 756146
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell methylation status and the transcriptional activity of NAT1 in breast cancer tissues: methylation of NAT1 gene is identified in 39 of the breast carcinomas (54.2%), 23 normal (76.7%) and 25 benign breast tissue samples (80.6%). Breast cancer tissues show significantly lower methylation rates of the NAT1 promoters than the normal and benign tissues. Cancer tissues show lower methylation density rates than normal and benign breast tissues. Tissues that show aberrant methylation of NAT1 show significantly less mRNA expression compared with the unmethylated cases. 20 cancers from the methylated group show positive staining for the estrogen receptor (ER) (51.3%), while 72.7% from the unmethylated group stain positive 689296
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell NAT1 is overexpressed in estrogen receptor-positive breast cancer 686256
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell patients with ductal carcinoma 676155
Show all pathways known for 2.3.1.57Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.57diamine N-acetyltransferase breast cancer cell - 756851
Show all pathways known for 2.3.1.57Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.57diamine N-acetyltransferase breast cancer cell in breast tumors, SSAT is increased contributing to an increase in acetylated polyamines 701622
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.85fatty-acid synthase system breast cancer cell - 704079, 705999
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43protein-lysine desuccinylase (NAD+) breast cancer cell - 758247
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B461-acylglycerophosphatidylinositol O-acyltransferase breast cancer cell - 757632
Display the word mapDisplay the reaction diagram Show all sequences 2.3.2.13protein-glutamine gamma-glutamyltransferase breast cancer cell MDA-MB-231 (doxorubicin resistant) human breast cancer cell 685934
Show all pathways known for 2.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 2.3.2.2gamma-glutamyltransferase breast cancer cell - 694485
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase breast cancer cell - 759882
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.150N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase breast cancer cell GCNT2 is overexpressed in highly metastatic breast cancer cell lines. GCNT2 expression is also significantly correlated to the metastatic phenotype in breast tumor samples 758992
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.1524-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase breast cancer cell - 735901
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.155alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase breast cancer cell - 693867
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.155alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase breast cancer cell epithelial and metastatic 758997
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.212hyaluronan synthase breast cancer cell - 736064, 736145
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.222O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase breast cancer cell manic fringe is highly expressed in claudin-low breast cancer 735881
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.313protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase breast cancer cell - 725164
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.80ceramide glucosyltransferase breast cancer cell - 722787, 736201
Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.12nicotinamide phosphoribosyltransferase breast cancer cell - 735872
Show all pathways known for 2.4.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.3uridine phosphorylase breast cancer cell - 705806
Results 1 - 100 of 309 > >>